SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bolan Peggie

(Last)

(First)

(Middle)

2645 SILVER CRESCENT DRIVE

(Street)

CHARLOTTE

28273

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/06/2024

3. Issuer Name and Ticker or Trading Symbol
JELD-WEN Holding, Inc. [ JELD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, GM NA Bldg Prod & Fiber

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	36,500⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock Option (Right to Buy)	⁽²⁾	05/01/2024	Common Stock	1,408	$18.79	D
Common Stock Option (Right to Buy)	⁽²⁾	02/26/2028	Common Stock	4,455	$33.34	D
Common Stock Option (Right to Buy)	⁽²⁾	02/25/2029	Common Stock	3,901	$20.96	D
Common Stock Option (Right to Buy)	⁽²⁾	02/11/2030	Common Stock	3,392	$24.54	D

Explanation of Responses:

1. The reported transaction includes the following awards made in respect of the issuer's common stock, the vesting of which is subject to the reporting person's continued employment with the issuer:(i) 4,745 restricted stock units granted on February 23, 2021, the remaining balance of which shall vest on February 23, 2024, (ii) 9,917 restricted stock units granted on May 3, 2021 which shall vest in full on May 3, 2024, (iii) 14,000 restricted stock units granted on February 14, 2023, which shall vest ratably on February 14, 2024, February 14, 2025, and February 14, 2026, and (iv) 5,000 restricted stock units granted on September 1, 2023, which shall vest 1/2 on the anniversary date in years 2 and 3.

2. This option is fully vested.

Remarks:

	/s/Willie White as attorney-in-fact for Peggie Bolan	02/08/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.